Jean-Charles Soria to Serum Albumin
This is a "connection" page, showing publications Jean-Charles Soria has written about Serum Albumin.
Connection Strength
0.064
-
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score). Eur J Cancer. 2017 10; 84:212-218.
Score: 0.032
-
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials. Invest New Drugs. 2018 02; 36(1):62-74.
Score: 0.032